An Overview of Quality of Life in Europe

Ahrendt, Daphne; Dubois, Hans; Mezger, Erika

doi:10.1007/978-94-017-9178-6_29

Cited by 20 publications

(28 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The median WHO-5 score was 56.0 [44.0] for patients with dementia, 44.0 [52.0] for patients with mood disorder and 48.0 [37.0] for patients with MCI/SCD. The European Quality of Life Survey 2016 reported a mean WHO-5 score of 65.0 among the general elderly German population aged 65 years and older [ 19 ]. A normative examination of the GAD-7 questionnaire among the general German population published in 2017 reported a mean GAD-7 score of 3.57 (SD 3.38) without a substantial age trend [ 20 ].…”

Section: Resultsmentioning

confidence: 99%

The impact of COVID-19-related distress on levels of depression, anxiety and quality of life in psychogeriatric patients

Miklitz

Westerteicher

Lippold

et al. 2021

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

Within the elderly population, psychogeriatric patients may be particularly susceptible to negative mental health effects of the coronavirus crisis. Detailed information about the psychosocial well-being of psychogeriatric patients during the pandemic is still sparse. Here we examined which aspects of subjective experience of the COVID-19 pandemic especially affect levels of depression, anxiety and quality of life in psychogeriatric patients with and without cognitive impairment. A cross-sectional paper survey was conducted during the first German lockdown among patients with a diagnosed psychiatric disorder (≥ 60 years) or a diagnosed neurodegenerative disease (regardless of their age) from the department for neurodegenerative diseases and geriatric psychiatry at the University of Bonn. The WHO-5-, GAD-7- and WHOQOL-old score were used to determine levels of depression, anxiety and quality of life. The second part obtained information about the subjective experience of the COVID-19 pandemic. Statistical analysis included among others principal component analysis and multiple linear regression analysis. COVID-19-related, immediate distress was a strong predictor of elevated symptoms of depression, anxiety and a reduced quality of life. COVID-19-related concerns regarding health and financial security, however, were not significantly associated with negative mental health outcomes. The overall prevalence of symptoms of depression (50.8% [95% CI 43.8–57.6%]) and anxiety (32.7% [95% CI 26.4–39.2%]) among psychogeriatric patients was high. Our findings indicate that psychogeriatric patients are not significantly affected by COVID-19-related concerns but are primarily suffering from emotional consequences resulting from changed living conditions due to the pandemic. Supplementary Information The online version contains supplementary material available at 10.1007/s00406-021-01340-1.

show abstract

Section: Resultsmentioning

confidence: 99%

The impact of COVID-19-related distress on levels of depression, anxiety and quality of life in psychogeriatric patients

Miklitz

Westerteicher

Lippold

et al. 2021

Eur Arch Psychiatry Clin Neurosci

View full text Add to dashboard Cite

show abstract

“…In a reasonable agreement with our results, the life satisfaction by country reported in the most recent WHR (2017-2019) was also ranked higher in the MED countries, SP ≈ IT = 6.4 > PT = 5.9 than in NMK = 5.2 and BG = 5.1 [47]. Similarly, the European Quality of Life Survey (2016) indicated that BG and NMK showed lower life satisfaction values (5.6 and 5.1, respectively) than SP, PT and IT (7.0, 6.9 and 6.6, respectively) [48], and data from the OECD (2018) established a similar ranking for MED countries (SP 7.7, IT 7.4, and PT 7.2) [49]. All these results point to some common issues:…”

Section: Discussionmentioning

confidence: 99%

Exploring Hedonic and Eudaimonic Items of Well-Being in Mediterranean and Non-Mediterranean Countries: Influence of Sociodemographic and Lifestyle Factors

Andrade

Quarta

Tagarro

et al. 2022

IJERPH

View full text Add to dashboard Cite

Increased understanding of subjective well-being (SWB), as well as factors that influence it, are essential to enhance well-being at the individual and national level. We have applied a hedonic and eudaimonic 9-item composed tool (SWB score) to measure SWB across several Mediterranean (MED) and non-Mediterranean (non-MED) countries, and to explore the association between the SWB score and a range of sociodemographic, health and Mediterranean lifestyle factors. A specifically designed web-based questionnaire was distributed to adult participants (N = 2400) from Spain, Italy, Portugal, Bulgaria and Republic of North Macedonia. Results showed that the SWB score was significantly different across the examined countries with the MED participants displaying slightly higher average scores than the non-MED ones (6.3 ± 1.5 vs. 6.1 ± 1.6, p = 0.002). Several sociodemographic, health status and lifestyle factors displayed a significant but limited association with the 9-item SWB score, with a multiple regression model explaining around 17% of the variance. Nevertheless, our results support that a closer adherence to Mediterranean lifestyle habits—the Mediterranean Diet, spending time with friends, family, and in nature, being active, and getting adequate rest at night—has a positive influence on the 9-item SWB score. Further research is needed to advance the understanding of the measuring and differentiating of SWB across different populations and to establish all the factors that influence it.

show abstract

“…This result is coupled with a negative correlation between vaccine hesitancy and trust measures. With the assumption that the level of trust in the institutions that develop, distribute and deliver vaccines is reflected in the survey trust measures, these two results suggest that to decrease vaccine hesitancy in the early stage of the vaccine rollout, policy makers must engage in a clear, transparent and continuous communication about the vaccines and their potential side effects [ 56 ]. After all, it has been demonstrated that transparency sustains trust in health authorities and hinders the spread of conspiracy beliefs, without necessarily reducing intentions to be vaccinated [ 63 , 64 ].…”

Section: Discussionmentioning

confidence: 99%

“…To the best of the authors’ knowledge, it is the only large-scale survey that provides EU-wide information about attitudes towards COVID-19 vaccination and coincides with the AstraZeneca vaccine controversy and suspensions. The majority of the survey questions were based on those used in the European Quality of Life Surveys (EQLS) [ 56 ] and the European Working Conditions Surveys (EWCS) [ 57 ].…”

Section: Methodsmentioning

confidence: 99%

Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries

et al. 2022

View full text Add to dashboard Cite

The success of mass vaccination programs against SARS-CoV-2 hinges on the public’s acceptance of the vaccines. During a vaccine roll-out, individuals have limited information about the potential side-effects and benefits. Given the public health concern of the COVID pandemic, providing appropriate information fast matters for the success of the campaign. In this paper, time-trends in vaccine hesitancy were examined using a sample of 35,390 respondents from the Eurofound’s Living, Working and COVID-19 (LWC) data collected between 12 February and 28 March 2021 across 28 European countries. The data cover the initial stage of the vaccine roll-out. We exploit the fact that during this period, news about rare cases of blood clots with low blood platelets were potentially linked to the Oxford/AstraZeneca vaccine (or Vaxzeveria). Multivariate regression models were used to analyze i) vaccine hesitancy trends, and whether any trend-change was associated with the link between the AstraZeneca vaccine ii) and blood clots (AstraZeneca controversy), and iii) the suspension among several European countries. Our estimates show that vaccine hesitancy increased over the early stage of the vaccine roll-out (0·002, 95% CI: [0·002 to 0·003]), a positive shift took place in the likelihood of hesitancy following the controversy (0·230, 95% CI: [0·157 to 0·302]), with the trend subsequently turning negative (-0·007, 95% CI: [-0·010 to -0·005]). Countries deciding to suspend the AstraZeneca vaccine experienced an increase in vaccine hesitancy after the suspensions (0·068, 95% CI: [0·04 to 0·095]). Trust in institutions is negatively associated with vaccine hesitancy. The results suggest that SARS-CoV-2 vaccine hesitancy increased steadily since the beginning of the vaccine roll-out and the AstraZeneca controversy and its suspension, made modest (though significant) contributions to increased hesitancy.

show abstract

An Overview of Quality of Life in Europe

Cited by 20 publications

References 12 publications

The impact of COVID-19-related distress on levels of depression, anxiety and quality of life in psychogeriatric patients

The impact of COVID-19-related distress on levels of depression, anxiety and quality of life in psychogeriatric patients

Exploring Hedonic and Eudaimonic Items of Well-Being in Mediterranean and Non-Mediterranean Countries: Influence of Sociodemographic and Lifestyle Factors

Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries

Contact Info

Product

Resources

About